Literature DB >> 2513643

Qualitative studies of gastric endocrine cells in patients treated long-term with omeprazole.

E Solcia1, G Rindi, N Havu, G Elm.   

Abstract

A total of 543 endoscopic biopsies (a mean of three tissue samples each) were taken from the gastric oxyntic mucosa of 122 patients suffering from reflux oesophagitis or peptic ulcer resistant to H2-receptor antagonist therapy. All were treated with omeprazole, 40 mg/day, until healing and then assigned to 20 mg/day for a mean of 13 months. Proliferative changes of endocrine cells were evaluated according to an internationally agreed classification and the paraffin sections were stained with haematoxylin-eosin and Sevier-Munger silver. Only hyperplastic (no dysplastic or neoplastic) lesions of endocrine cells were observed in 11-19% of patients examined, the incidence and severity of these lesions being unaffected by treatment. A relationship between linear and/or micronodular hyperplasia and chronic gastritis was observed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2513643     DOI: 10.3109/00365528909091260

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN: 0085-5928


  21 in total

1.  U.S. experience with omeprazole in duodenal ulcer. Multicenter double-blind comparative study with ranitidine. The Omeprazole DU Comparative Study Group.

Authors:  J E Valenzuela; R G Berlin; W J Snape; T L Johnson; B I Hirschowitz; J Colon-Pagan; R S Morse; J Petrozza; G M Van Deventer; A Cagliola
Journal:  Dig Dis Sci       Date:  1991-06       Impact factor: 3.199

2.  Multifocal gastric carcinoid tumor in a patient with pernicious anemia receiving lansoprazole.

Authors:  Tan Attila; Raj Santharam; Dennis Blom; Richard Komorowski; Timothy R Koch
Journal:  Dig Dis Sci       Date:  2005-03       Impact factor: 3.199

3.  Omeprazole.

Authors: 
Journal:  BMJ       Date:  1991-10-05

4.  Omeprazole: gastrin and gastric data (August 1991)

Authors:  R G Berlin
Journal:  Dig Dis Sci       Date:  1991-10       Impact factor: 3.199

5.  Evaluation of a proposed technique to assess unscheduled DNA synthesis and genotoxicity.

Authors:  R A Goodlad; C Y Lee; M R Alison; C E Sarraf; M A Ghatei; S R Bloom; N A Wright
Journal:  Gut       Date:  1993-02       Impact factor: 23.059

6.  Observations on relationship between hypergastrinemia, multiple gastric carcinoids, and pancreatic mass.

Authors:  I M Modlin; C J Gilligan; G P Lawton; L H Tang; A B West; R Lindenberg
Journal:  Dig Dis Sci       Date:  1996-01       Impact factor: 3.199

Review 7.  Acid suppression and claims of genotoxicity. What have we learned?

Authors:  R A Goodlad
Journal:  Drug Saf       Date:  1994-06       Impact factor: 5.606

Review 8.  Acid suppression and gastric mucosal cell biology.

Authors:  G Delle Fave; H Helander; S Holt; I M Modlin; R Powers; E Solcia; A Soll; Y Tielemans; N A Wright
Journal:  Dig Dis Sci       Date:  1994-09       Impact factor: 3.199

Review 9.  Adverse effects of long-term proton pump inhibitor therapy.

Authors:  Edward Sheen; George Triadafilopoulos
Journal:  Dig Dis Sci       Date:  2011-03-02       Impact factor: 3.199

10.  Gastric argyrophil (enterochromaffin-like), gastrin, and somatostatin cells after proximal selective vagotomy in man.

Authors:  H Koop; M Frank; S Kuly; R Nold; R Eissele; G Rager; J Rüschoff; M Rothmund; R Arnold
Journal:  Dig Dis Sci       Date:  1993-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.